Frequency of Hypoglycemia in Patients With Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real Life

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

161 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-11-28

Study Completion Date

2020-06-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Diabetes is a chronic and progressive disease that affects nearly 3.5 million people in France.

Currently the investigators are seeing an aging of the population explained by the increase in life expectancy and thus an increasing incidence of diabetes in the elderly. However, the frequency of hypoglycemia in older vulnerable patients remains poorly characterized

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy of Flash Glucose-Sensing Technology on the Occurrence of Cardiac Arrhythmias Associated With Hypoglycemia

NCT03570138

Insulin Treated Type 2 Diabetes With High Risk of Hypoglycemia

UNKNOWN NA

Screening for Hypoglycemia in an Institutionalized Elderly Diabetic Population.

NCT03656887

Old Age Institutionalized in EHPAD (French Nursing Home) Diabetes +1 more

COMPLETED

Satisfaction of Hospitalized Diabetic Patients Using a Continuous Glucose Monitoring System

NCT03411460

Insulin-Dependent Diabetes

TERMINATED NA

Impact on Hypoglycaemia Awareness of Real Time CGM and Intermittent Continuous Glucose Data

NCT03028220

Type 1 Diabetes Mellitus With Hypoglycemia Impaired Awareness of Hypoglycemia Type1diabetes

COMPLETED NA

How Common is Hypoglycaemia in Older People With Diabetes Who Fall?

NCT05470842

Diabetes Hypoglycaemia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type2 Diabetes Elderly Hypoglycemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients older than 75 years

Collection of hypoglycaemia épisodes with the glycemic sensor FREESTYLE Libre Pro

Group Type EXPERIMENTAL

glycemic sensor FREESTYLE Libre Pro

Intervention Type DEVICE

Collection of hypoglycemia episodes with glycemic sensor FREESTYLE Libre Pro

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

glycemic sensor FREESTYLE Libre Pro

Collection of hypoglycemia episodes with glycemic sensor FREESTYLE Libre Pro

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female ≥ 75 years of age;
* Type 2 diabetes for at least 1 year and treated with insulin for at least 6 months;
* Treated with basal insulin (ie glargine U100: Lantus®, Abasaglar®, glargine U300: Toujeo®, detemir: levemir®, NPH), premix (ie Novomix® and Humalog Mix®), and / Insulin associated or not with one or more oral and / or injectable antidiabetic agents (analog of GLP1...);
* Benefiting from at least 1 capillary glucose per day (carried out by the patient himself or a caregiver);
* Benefiting from a standardized geriatric assessment;
* Signature of informed consent
* Patient benefiting from a social security system.

Exclusion Criteria

* Male or female aged \<75 years;
* Person without diabetes or type 1 diabetes;
* Patient treated only lifestyle modifications and / or oral anti-diabetic drugs and / or GLP-1 receptor agonists alone;
* Subjects with secondary or corticosteroid-induced diabetes;
* Refusal to participate in the study or inability to collect consent;
* Patient for whom follow-up of the study procedures is impossible (glycemic record impossible or insufficient);
* Patient not eligible for geriatric assessment;
* Patient already participating in another study;
* Patient with a severe pathology limiting his life expectancy (palliative care ...) compromising his participation in the study at the discretion of the investigator;
* Patient benefiting from a safeguard of justice.

Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No